Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for primary prevention in children at high genetic risk for type 1 diabetes
2015-003379-31Phase 2Completed
- Sponsor
- Technical University of Munich Faculty of Medicine
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin in diabetes mellitus type 1 (T1D), sponsored by Technical University of Munich Faculty of Medicine. Primary endpoint: Immune response to insulin. Started Sep 2016; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-003379-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003379-31.